Veracyte | VCYT - Ebitda

Preço das Ações
33.29
Mudança Diária
-0.19 -0.57%
Mensal
-8.24%
Anual
4.75%
Q1 Previsão
31.16




Ebitda Alterar Data
Agenus USD -10.11M 19.02M 2025-03
Agilent USD 540M 74M 2025-09
Anika Therapeutics USD -2.69M 4.73M 2025-03
Arrowhead Research USD 64.2M 223.53M 2025-09
Bruker USD 211.6M 207.4M 2025-12
Exact Sciences USD 135.42M 2.8M 2025-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Illumina USD 332M 12M 2025-09
Intrexon USD -24.7M 2.92M 2024-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Laboratory Of America USD 588.1M 24.1M 2025-12
Ligand Pharmaceuticals USD 150.32M 129.42M 2025-09
Myriad Genetics USD 10.3M 4.2M 2025-09
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Roche Holding CHF 12.68B 2.36B 2024-06
Siemens EUR 3.64B 535M 2025-12
Sonic Healthcare AUD 839.07M 51.09M 2024-12
Thermo Fisher Scientific USD 3.17B 335M 2025-12
Veracyte USD 42.31M 2.58M 2025-12
Waters USD 380.97M 85.83M 2025-12